Video Program for Alzheimer's Disease
(RT-D ADRD Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Resilient Together for Dementia (RT-D, RT-ADRD) for Alzheimer's Disease?
The RDAD program, which is similar to Resilient Together for Dementia, has been effective in teaching caregivers strategies to improve mood, behavior, and physical function in people with dementia. This suggests that similar approaches, like Resilient Together for Dementia, may also be beneficial.12345
What makes the Resilient Together for Dementia treatment unique compared to other treatments for Alzheimer's disease?
The Resilient Together for Dementia treatment is unique because it combines video programs designed to engage and calm individuals with dementia, providing caregivers with respite time, and involves caregivers in exercise activities to improve mood and behavior, which is different from traditional medication-based treatments.12367
What is the purpose of this trial?
The proposed study will establish the feasibility, acceptability and credibility of a novel live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at preventing chronic emotional distress and preserving quality of life among dyads at risk for chronic emotional distress early after a diagnosis of Alzheimer's disease or a related dementia (ADRD).
Research Team
Sarah Bannon
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
This trial is for pairs (dyads) where one person has early-stage Alzheimer's or related dementia and the other is a caregiver. They should be at risk of chronic emotional distress. Specific eligibility details are not provided, but typically there would be criteria around age, health status, and ability to participate in video sessions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Resilient Together for Dementia intervention via live video sessions
Follow-up
Participants are monitored for changes in emotional distress using the Hospital Anxiety and Depression Scale
Treatment Details
Interventions
- Resilient Together for Dementia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute on Aging (NIA)
Collaborator